Loading…

Presentation of Soluble Antigens by Mast Cells: Upregulation by Interleukin-4 and Granulocyte/Macrophage Colony-Stimulating Factor and Downregulation by Interferon-γ

We recently showed that bone marrow-derived mast cells bore MHC class II molecules and could present antigens to specific T cell hybridomas. This article summarizes the effects of purified recombinant cytokines on the expression of MHC class II molecules by mast cells and on their antigen-presenting...

Full description

Saved in:
Bibliographic Details
Published in:Cellular immunology 1995-06, Vol.163 (1), p.37-46
Main Authors: Frandji, Pierre, Tkaczyk, Christine, Oskéritzian, Carole, Lapeyre, Josette, Peronet, Roger, David, Bernard, Guillet, Jean-Gérard, Mécheri, Salaheddine
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We recently showed that bone marrow-derived mast cells bore MHC class II molecules and could present antigens to specific T cell hybridomas. This article summarizes the effects of purified recombinant cytokines on the expression of MHC class II molecules by mast cells and on their antigen-presenting capacity. Since IL-3 is essential for mast cell growth, all the cytokines were analyzed in the presence of IL-3. IL-3 downregulated the production of Ia molecules, so that mast cells cultured in IL-3 alone had no antigen presenting ability. In contrast, IL-4 and IFN-7 upregulated the production of MHC class II molecules, while GM-CSF had no effect. The antigen-presenting capacity of IL-4-treated mast cells was substantially enhanced by incubating these cells with GM-CSF for 2 days. GM-CSF enhanced antigen presentation only in combination with IL-4. The activation of mast cells was reversible and could not be repeated. Finally, incubation of IL-4- or IL-4/GM-CSF-treated mast cells with IFN-γ led to almost complete inhibition of the antigen-presenting function. These findings provide new insights into the regulation of specific allergic responses.
ISSN:0008-8749
1090-2163
DOI:10.1006/cimm.1995.1096